#CMSC16 – Metabolism in MS and the Role of Mitochondrial Dysfunction
One June 3, a workshop titled “Metabolism in MS and Related Conditions” was presented at the 2016 Annual Meeting…
Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
One June 3, a workshop titled “Metabolism in MS and Related Conditions” was presented at the 2016 Annual Meeting…
There is a greater number of older people with multiple sclerosis than ever before, and the number is likely to…
The use of assistive devices is ineffective for multiple sclerosis (MS) patients, a study recently presented at the Consortium of…
Two case reports from the Sheltering Arms Physical Rehabilitation Centers presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016…
Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance…
Research from Indiana University School of Medicine showed that D3T – a compound that triggers copying of antioxidant genes and production…
Data recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting showed that Roche/Genentech’s investigational…
A study of relapsing-remitting multiple sclerosis (RRMS) patients who had one or more relapses on earlier treatment, showed that…
A study, recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting in National Harbor, Md., showed…
Dr. Rosalind Kalb, vice president of the Professional Resource Center at the National Multiple Sclerosis Society in New York City,…
The “Comprehensive Care in MS and Symptom Management” session at the Consortium of Multiple Sclerosis Centers (CMSC) 2016…
Multiple sclerosis (MS) patients using an interactive, self-guided fatigue management resource, developed by researchers from the University of Alberta…
One of the highlights at the “Comprehensive Care in MS and Symptom Management” session of the Consortium of…
Identifying multiple sclerosis (MS) patients who suffer from dysphagia — swallowing difficulties — early on allows the prevention of aspiration…
People with primary progressive multiple sclerosis (PPMS) are usually older and more disabled than those with relapsing-remitting MS, researchers at Washington University reported. The team…
The use of induced pluripotent stem cells to create disease-specific neurons and oligodendrocytes for the study of multiple sclerosis (MS)…
On June 2, a symposium titled “Cell-based therapies in MS” was presented at the 2016 Annual Meeting of the…
Exercise might improve sleep quality in people with multiple sclerosis (MS), according to a study presented at the Consortium…
While most multiple sclerosis (MS) researchers focus on the autoimmune and inflammatory processes of the disease, researchers at the…
A symposium focused on lifestyle factors and unconventional medicine as part of the clinical care provided to patients with multiple…
Dr. Fred Lublin, a renowned multiple sclerosis (MS) expert at Mount Sinai Medical Center, helped launch the Consortium of Multiple Sclerosis Centers…
The Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting began today, June 1. Multiple Sclerosis News Today is providing extensive on-site coverage of…
Zinbryta (daclizumab) was approved May 27 for the treatment of adults with relapsing multiple sclerosis (MS). The U.S.
Data from an extension phase of a Phase 3 clinical trial, given in an oral presentation by MedDay, reported that the…
The Russian Ministry of Health recently granted Marketing Authorization (ЛП-003567) to R-Pharm JSC for the development of “Glatirat” (Glatiramer…
Sanofi Genzyme recently launched vs.MS, a global initiative to raise awareness of the often unspoken physical and emotional burden…
Yissum Research Development Company, an arm of Hebrew University of Jerusalem, has entered into an agreement with Aurum…
A mutation in a mouse model of the John Cunningham (JC) virus, which causes progressive multifocal leukoencephalopathy (PML), allows the virus to…
With the Consortium of Multiple Sclerosis Centers (CMSC) 2016 fast approaching, Multiple…
ReWalk Robotics, Ltd., announced it is partnering with the Wyss Institute for Biologically Inspired Engineering at Harvard University to further develop and…
Get regular updates to your inbox.